447
Views
50
CrossRef citations to date
0
Altmetric
Research Article

The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population

, , , , , , , , , , , , , , , , & show all
Pages 10-14 | Accepted 22 Aug 2011, Published online: 01 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ola Atef Sharaki, Amira Hasan Elgerby, Eman Saad Nassar & Sara Salah Eldin Khalil. (2018) Impact of methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism on the outcome of methotrexate treatment in a sample of Egyptian rheumatoid arthritis patients. Alexandria Journal of Medicine 54:4, pages 633-638.
Read now
T Dimitroulas, A Sandoo, J Hodson, J Smith, KM Douglas & GD Kitas. (2016) Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis. Scandinavian Journal of Rheumatology 45:4, pages 267-273.
Read now
M Fodil, VH Teixeira, V Chaudru, P Hilliquin, S Bombardieri, A Balsa, R Westhovens, P Barrera, H Alves, P Migliorin, T Bardin, F Cornelis, A Boudjema & E Petit-Teixeira. (2015) Relationship between SNPs and expression level for candidate genes in rheumatoid arthritis. Scandinavian Journal of Rheumatology 44:1, pages 2-7.
Read now

Articles from other publishers (47)

Atinuke Aluko & Prabha Ranganathan. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 527 567 .
G. V. Volynets & A. I. Khavkin. (2021) Inflammatory bowel disease and drug-induced liver damage. Experimental and Clinical Gastroenterology:10, pages 138-146.
Crossref
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo & Maria Rendina. (2021) Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 13:11, pages 1534-1551.
Crossref
Alejandro Escudero-Contreras, Clementina López-Medina, Eduardo Collantes-Estévez, Rafaela Ortega-Castro, Jerusalem Calvo-Gutiérrez, Natalia Mena-Vázquez, Blanca Panero-Lamothe, Bárbara Manzanares-Martín, Rafael Cáliz-Cáliz, Alberto Jiménez-Morales, Mayte Ruiz-Jiménez & Pilar Font-Ugalde. (2021) Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis. Journal of Clinical Medicine 10:18, pages 4070.
Crossref
Johanna Karlsson Sundbaum, Eva Baecklund, Niclas Eriksson, Pär Hallberg, Hugo Kohnke & Mia Wadelius. (2020) MTHFR , TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis . Pharmacogenomics 21:5, pages 337-346.
Crossref
Shengli Wang, Shuguang Zuo, Zhigang Liu, Xinying Ji, Zhenqiang Yao & Xinchun Wang. (2019) Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis . Journal of International Medical Research 48:2, pages 030006051987958.
Crossref
Zhiyuan Tan, Wei Liu, Hua Guo, Kai Hu & Rongsheng Zhao. (2019) Severe toxic effects of low‐dose methotrexate treatment for placenta accreta in a patient with methylenetetrahydrofolate reductase mutations. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 214-217.
Crossref
Jing Huang, Huizhen Fan, Qi Qiu, Kunpeng Liu, Shuang Lv, Jiang Li, Hui Yang, Xiaoming Shu, Yuan Xu, Xiangchen Lu, Cheng Lu, Yunnan Zhang & Cheng Xiao. (2020) Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis. Therapeutic Advances in Chronic Disease 11, pages 204062232091602.
Crossref
Pedro De Marchi, Matias E. Melendez, Ana C. Laus, Pamela A. Kuhlmann, Ana Carolina de Carvalho, Lidia Maria R.B. Arantes, Adriane F. Evangelista, Edilene S. Andrade, Gilberto de CastroJuniorJunior, Rui M. Reis, André Lopes Carvalho & Luciano de Souza Viana. (2019) The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral Oncology 98, pages 48-52.
Crossref
Xin Wu, Xiaobao Sheng, Rong Sheng, Hongjuan Lu & Huji Xu. (2019) Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis. Frontiers of Medicine 13:4, pages 411-419.
Crossref
Shuang Lv, HuiZhen Fan, Jiang Li, Hui Yang, Jing Huang, XiaoMing Shu, Lu Zhang, Yuan Xu, Xiaoya Li, Jieyu Zuo & Cheng Xiao. (2018) Genetic Polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR Are Related to the Outcome of Methotrexate Therapy for Rheumatoid Arthritis in a Chinese Population. Frontiers in Pharmacology 9.
Crossref
Manahel Mahmood AlSabbagh. (2018) Association of MTHF 677TT with adverse drug reactions and RFC G80A with non-response and adverse drug reactions in methotrexate therapy. Personalized Medicine Universe 7, pages 19-27.
Crossref
Luis Sala-Icardo, Amalia Lamana, Ana María Ortiz, Elena García Lorenzo, Pablo Moreno Fresneda, Rosario García-Vicuña & Isidoro González-Álvaro. (2017) Impact of Genetic Variants of ATP Binding Cassette B1, AICAR Transformylase/IMP Cyclohydrolase, Folyl-polyglutamate Synthetase, and Methylenetetrahydrofolate Reductase on Methotrexate Toxicity. Reumatología Clínica (English Edition) 13:6, pages 318-325.
Crossref
Luis Sala-Icardo, Amalia Lamana, Ana María Ortiz, Elena García Lorenzo, Pablo Moreno Fresneda, Rosario García-Vicuña & Isidoro González-Álvaro. (2017) Impacto de variantes genéticas del transportador de membrana que une ATP B1, la aicar transformilasa/IMP ciclohidrolasa, la folilpoliglutamatosintetasa y la metilen-tetrahidrofolatorreductasa en la toxicidad de metotrexato. Reumatología Clínica 13:6, pages 318-325.
Crossref
Lilya M. Berkani, Fadia Rahal, Ines Allam, Soraya Mouaki Benani, Aïcha Laadjouz & Reda Djidjik. (2017) Association of MTHFR C677T and A1298C gene polymorphisms with methotrexate efficiency and toxicity in Algerian rheumatoid arthritis patients. Heliyon 3:11, pages e00467.
Crossref
Hongqiong Fan, Yanhui Li, Li Zhang, Yuying Li & Wei Li. (2017) Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta‐analysis . International Journal of Rheumatic Diseases 20:5, pages 526-540.
Crossref
Wenjing ShaoYi YuanYuying Li. (2017) Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis . Genetic Testing and Molecular Biomarkers 21:5, pages 275-285.
Crossref
Qi Qiu, Jing Huang, Yang Lin, Xiaoming Shu, Huizheng Fan, Zhihua Tu, Youwen Zhou & Cheng Xiao. (2017) Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis. Medicine 96:11, pages e6337.
Crossref
My-Linh Tran-Minh, Paula Sousa, Marianne Maillet, Matthieu Allez & Jean-Marc Gornet. (2017) Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World Journal of Hepatology 9:13, pages 613.
Crossref
Yuehong Chen, Kun Zou, Jianhong Sun, Yuan Yang & Gang Liu. (2017) Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis. Pharmacogenomics 18:2, pages 175-195.
Crossref
Andrea Scheuern, Nadine Fischer, Joseph McDonald, Hermine I. Brunner, Johannes-Peter Haas & Boris Hügle. (2016) Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis. Pediatric Rheumatology 14:1.
Crossref
C Ciccacci, P Conigliaro, C Perricone, S Rufini, P Triggianese, C Politi, G Novelli, R Perricone & P Borgiani. (2016) Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis. Clinical and Experimental Immunology 186:2, pages 157-163.
Crossref
Aurea Lima, Miguel Bernardes, Rita Azevedo, Vitor Seabra & Rui Medeiros. (2016) Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome. Pharmacogenomics 17:15, pages 1649-1674.
Crossref
XiaoBing Li, MingCai Hu, WanPing Li, Li Gu, MeiJuan Chen, HuiHua Ding, Kamala Vanarsa & Yong Du. (2016) The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis. International Immunopharmacology 38, pages 8-15.
Crossref
Ming Zhao, Liang Liang, Liwei Ji, Di Chen, Yatong Zhang, Yuanchao Zhu & Alessia Ongaro. (2016) MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis . Pharmacogenomics 17:9, pages 1005-1017.
Crossref
Yi-Kong Keung, Lap-Woon Keung & Eddie Hong-Lung Hu. (2015) A case of recurrent pancytopenia in a patient with acute promyelocytic leukemia on maintenance chemotherapy and concomitant methyltetrahydrofolate reductase and thiopurine S-methyltransferase mutation - review of literature. Journal of Oncology Pharmacy Practice 22:3, pages 548-551.
Crossref
Luisa F. Restrepo, Rodrigo Giraldo, John Londoño, Carlos Pinzón, Ani Cortes, Giovanny Ballesteros & Ana María Santos. (2016) Pharmacogenetics of methotrexate in rheumatoid arthritis: A systematic review. Revista Colombiana de Reumatología (English Edition) 23:2, pages 102-114.
Crossref
Luisa F. Restrepo, Rodrigo Giraldo, John Londoño, Carlos Pinzón, Ani Cortes, Giovanny Ballesteros & Ana María Santos. (2016) Farmacogenética del metotrexato en artritis reumatoide. Revisión sistemática. Revista Colombiana de Reumatología 23:2, pages 102-114.
Crossref
S Jabeen, L Holmboe, G I G Alnæs, A M Andersen, K S Hall & V N Kristensen. (2015) Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. The Pharmacogenomics Journal 15:5, pages 385-390.
Crossref
Patricia Moya, Hèctor Corominas, Juliana Salazar & Montserrat Baiget. (2015) Consensus on the Use of Methotrexate Beyond the Clinical Recommendation: Adjusted Dose and Pharmacogenetics. Reumatología Clínica (English Edition) 11:4, pages 261-262.
Crossref
Patricia Moya, Hèctor Corominas, Juliana Salazar & Montserrat Baiget. (2015) Consenso sobre el uso de metotrexato más allá de la recomendación clínica: dosis ajustada y farmacogenética. Reumatología Clínica 11:4, pages 261-262.
Crossref
Yui Tazoe, Hideki Hayashi, Seiji Tsuboi, Tomone Shioura, Taiji Matsuyama, Hiroshi Yamada, Keita Hirai, Daiki Tsuji, Kazuyuki Inoue, Tadashi Sugiyama & Kunihiko Itoh. (2015) Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis. Drug Metabolism and Pharmacokinetics 30:3, pages 227-230.
Crossref
Vasco C. Romão, Aurea Lima, Miguel Bernardes, Helena Canhão & João Eurico Fonseca. (2014) Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?. Immunologic Research 60:2-3, pages 289-310.
Crossref
Gwan Gyu Song, Sang-Cheol Bae & Young Ho Lee. (2014) Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clinical Rheumatology 33:12, pages 1715-1724.
Crossref
Ling Ling Zhang, Sen Yang, Wei Wei & Xue Jun Zhang. (2014) Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis. Pharmacogenetics and Genomics 24:11, pages 531-538.
Crossref
Elena Nikiphorou, Andra Negoescu, John D. Fitzpatrick, Calum T. Goudie, Andrew Badcock, Andrew J. K. Östör & Anshuman P. Malaviya. (2014) Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. Clinical Rheumatology 33:5, pages 609-614.
Crossref
Tabitha N. Kung, Jessica Dennis, YiQing Ma, Gang Xie, Vivian Bykerk, Janet Pope, Carter Thorne, Edward Keystone, Katherine A. Siminovitch & France Gagnon. (2014) RFC1 80G>A Is a Genetic Determinant of Methotrexate Efficacy in Rheumatoid Arthritis: A Human Genome Epidemiologic Review and Meta-Analysis of Observational Studies . Arthritis & Rheumatology 66:5, pages 1111-1120.
Crossref
Hong Zhu, Fei-Yan Deng, Xing-Bo Mo, Ying-Hua Qiu & Shu-Feng Lei. (2014) Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update. Pharmacogenomics 15:4, pages 551-566.
Crossref
Rajalingham Sakthiswary, Grace Yin Lai Chan, Ee Tzun Koh, Khai Pang Leong & Bernard Yu Hor Thong. (2014) Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis. The Scientific World Journal 2014, pages 1-5.
Crossref
Jisna R Paul, Deepali Sen & Prabha Ranganathan. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine 653 681 .
Deepali Sen, Jisna R. Paul & Prabha Ranganathan. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development 625 660 .
Maša Umićević Mirkov & Marieke JH Coenen. (2013) Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Pharmacogenomics 14:4, pages 425-444.
Crossref
Fardina Malik & Prabha Ranganathan. (2013) Methotrexate pharmacogenetics in rheumatoid arthritis: a status report. Pharmacogenomics 14:3, pages 305-314.
Crossref
Cristina Lucía Dávila-Fajardo, Jesse J Swen, José Cabeza Barrera & Henk-Jan Guchelaar. (2013) Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate. Pharmacogenomics 14:1, pages 63-73.
Crossref
José Cristian Plaza-PlazaMargarita AguileraMarisa Cañadas-GarreClarice ChemelloAlfonso González-UtrillaMaría José Faus DaderMiguel Angel Calleja. (2012) Pharmacogenetic Polymorphisms Contributing to Toxicity Induced by Methotrexate in the Southern Spanish Population with Rheumatoid Arthritis. OMICS: A Journal of Integrative Biology 16:11, pages 589-595.
Crossref
Lin Yang, Xin Hu & Luhang Xu. (2012) Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis. Tumor Biology 33:5, pages 1445-1454.
Crossref
Prabha Ranganathan. (2012) Research Highlights. Pharmacogenomics 13:4, pages 377-380.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.